Blood mitochondrial DNA mutations in HIV-infected women and their infants exposed to HAART during pregnancy
Authors:
- Beheroze SatthaBSBeheroze Sattha
- Evelyn J. MaanEMEvelyn J. Maan
- Izabelle GadawskiIGIzabelle Gadawski
- P. Richard HarriganPHP. Richard Harrigan
- John C. ForbesJFJohn C. Forbes
- Ariane AlimentiAAAriane Alimenti
- Julie van SchalkwykJSJulie van Schalkwyk
- Deborah M. MoneyDMDeborah M. Money
- Hélène C.F. CôtéHCHélène C.F. Côté
Open Access
- 27 March 2012
- journal article
- basic science
- Published by Wolters Kluwer Health in AIDS
- Vol. 26 (6) , 675-683
Abstract
Objectives: Nucleo(s/t)ide reverse transcriptase inhibitors given to HIV-infected pregnant women to prevent vertical transmission may adversely affect mitochondrial DNA (mtDNA). We hypothesized that HAART-exposed/HIV-uninfected infants may show higher blood mtDNA mutation burden than controls born to HIV-uninfected mothers. Methods: Blood was collected from in-utero HIV/HAART-exposed infants and controls, as well as from a subset of their mothers. The presence of mtDNA A→C/T→G (AC/TG) mutations was measured by cloning and sequencing D-loop PCR amplicons. Relationships with maternal characteristics were examined. Results: No significant difference was found between the percentage of HIV/HAART-exposed infants with AC/TG mutations (N = 15/57, 26.3%) and controls (N = 10/70, 14.3%) before (P = 0.090) or after controlling for covariates (P = 0.058), although a tendency was observed. However, significantly more HIV/HAART-exposed mothers (N = 18/42, 42.9%) harboured AC/TG mutations compared with controls (N = 7/39, 17.9%) before (P = 0.015) and after (P = 0.012) controlling for covariates. AC/TG mutations were more prevalent in HIV/HAART-exposed mothers than in their infants (N = 42, 42.9 vs. 23.8%, P = 0.033), however, this difference disappeared after controlling for covariates. No difference was seen between control mothers and their infants (N = 39, both 17.9%). In HIV/HAART-exposed mothers, only a detectable HIV plasma viral load near delivery predicted AC/TG mutations. Conclusion: Our results suggest that HIV and/or HAART exposure are associated with increased prevalence of AC/TG mtDNA mutations in mothers and show a similar tendency in infants exposed during pregnancy. As accumulation of mtDNA mutations has been linked with aging and age-associated diseases, this may raise concerns in the long term for HIV and HAART-exposed populations.Keywords
This publication has 41 references indexed in Scilit:
- Mitochondrial aging is accelerated by anti-retroviral therapy through the clonal expansion of mtDNA mutationsNature Genetics, 2011
- Antiretroviral Exposure and Lymphocyte mtDNA Content Among Uninfected Infants of HIV-1-Infected WomenPediatrics, 2009
- Opioid use affects antioxidant activity and purine metabolism: preliminary resultsHuman Psychopharmacology: Clinical and Experimental, 2009
- Mutational analysis of the mitochondrial tRNA genes and flanking regions in umbilical cord tissue from uninfected infants receiving AZT‐based therapies for prophylaxis of HIV‐1Environmental and Molecular Mutagenesis, 2008
- Mitochondrial DNA repair in aging and diseaseMechanisms of Ageing and Development, 2008
- HIV and pregnancyBMJ, 2007
- Systemic Effects of SmokingChest, 2007
- Anti-HIV drugs and the mitochondriaBiochimica et Biophysica Acta (BBA) - Bioenergetics, 2006
- Pharmacokinetics of Antiretrovirals in Pregnant WomenClinical Pharmacokinetics, 2004
- Aging-Dependent Large Accumulation of Point Mutations in the Human mtDNA Control Region for ReplicationScience, 1999